Skip to content

Achieve Life Sciences ACHV Proceeds From Realized Gain On Investments

Proceeds From Realized Gain On Investments at other companies

Marqeta logo
MarqetaMQ
$0
Kemper logo
KemperKMPR
$1.9M-73.4%
Northrim BanCorp logo
Northrim BanCorpNRIM
$250
Clearwater Analytics logo
Clearwater AnalyticsCWAN
$0-100%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$28K+1,300%
American International Group logo
American International GroupAIG
$0+100%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept achv:ProceedsFromRealizedGainOnInvestments.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's proceeds from realized gain on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's proceeds from realized gain on investments?
Achieve Life Sciences (ACHV) reported proceeds from realized gain on investments of $1K in Q4 2025.
What does proceeds from realized gain on investments mean?
Cash inflows representing the realized gains from the sale or maturity of investment assets. This reflects the performance of the company's treasury or investment portfolio management.